Antithrombin-III exerts antiinflammatory effects via ligation of heparan sulfate proteoglycans. Here we show in vitro that recombinant human antithrombin-III attenuates CD11b/CD18 expression of activated neutrophils and monocytes in whole blood ex vivo. As leukocyte integrin expression is triggered by extracorporeal circulation, this observation may be of relevance for pharmacological treatment during cardiopulmonary bypass.
KosterA.FischerT.PrausM.HaberzettlH.KueblerW.M.HetzerR.KuppeH., 2002. Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management. Anesthesiology97:83.
SlaughterT.F.MarkJ.K.El-MoalemH.HaywardK.A.HiltonA.K.HodginsL.P.GreenbergC.S., 2001. Hemostatic effects of antithrombin III supplementation during cardiac surgery: Results of a prospective randomized investigation. Blood Coagul. Fibrinolysis12:25.
4.
WilliamsM.R.D'AmbraA.B.BeckJ. R.SpanierT. B.MoralesD. L.HelmanD.N.OzM.C., 2000. A randomized trial of antithrombin concentrate for treatment of heparin resistance. Ann. Thorac. Surg.70:873.
5.
SonzogniV.BellavitaP.CarraraB.CossoliniM.FerriF.FabrettiF.MamprinF.PelliccioliI., 2000. The effect of antithrombin III concentrations during cardiopulmonary surgery. Minerva Anestesiol. 66:17.
6.
ErnofssonM.ThelinS.SiegbahnA., 1997. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study. J. Thorac. Cardiovasc. Surg.113:576.
7.
SundaramS.LimF.CooperS.L.ColmanR.W., 1996. Role of leucocytes in coagulation induced by artificial surfaces: Investigation of expression of Mac-1, granulocyte elastase release and leucocyte adhesion on modified polyurethanes. Biomaterials17:1041.
8.
YoshimuraY.HiramatsuY.SatoY.HommaS.EnomotoY.KikuchiY.SakakibaraY., 2003. Activated neutrophils and platelet microaggregates impede blood filterability through microchannels during simulated extracorporeal circulation. Ann. Thorac. Surg.75:1254.
9.
GrittiD.GasparettoC.MalinvernoA.RicevutiG., 2002. Inhibition of leukocyte and platelet aggregation in vitro by antithrombin. Acta Med. Austriaca29:97.
10.
MargreiterJ.MittermayrM.MairJ.Hammerer-LercherA.KountchevJ.KlinglerA.SchobersbergerW., 2002. Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart. Thromb. Res.108:249.
11.
NishijimaK.KiryuJ.TsujikawaA.HonjoM.NonakaA.YamashiroK.KamizuruH.IekiY.TaniharaH.HondaY.OguraY., 2003. Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci.44:332.
12.
OstrovskyL.WoodmanR.C.PayneD.TeohD.KubesP., 1997. Antithrombin III prevents and rapidly reverses leukocyte recruitment in ischemia/reperfusion. Circulation96:2302.
13.
HoffmannJ.N.VollmarB.RomischJ.InthornD.SchildbergF.W.MengerM.D., 2002. Antithrombin effects on endotoxin-induced microcirculatory disorders are mediated mainly by its interaction with microvascular endothelium. Crit. Care. Med.30:218.
14.
MizutaniA.OkajimaK.UchibaM.IsobeH.HaradaN.MizutaniS.NoguchiT., 2003. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood101:3029.
15.
WoodmanR.C.OstrovskyL.TeohD.PayneD.PoonM.C.KubesP., 1998. Antithrombin and ischemia/reperfusion. Blood. Coagul. Fibrinolysis9(S): S7.
16.
HoffmannJ.N.VollmarB.LaschkeM.W.InthornD.KaneiderN.C.DunzendorferS.WiedermannC.J.RomischJ.SchildbergF.W.MengerM.D., 2002. Adverse effect of heparin on antithrombin action during endotoxemia: Microhemodynamic and cellular mechanisms. Thromb. Haemost.88:242.
17.
KaneiderN.C.DjananiA.Fischer-ColbrieR.WiedermannC.J., 2002. Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochem. Biophys. Res. Commun.297:806.
18.
KaneiderN.C.ReinischC.M.DunzendorferS.RomischJ.WiedermannC.J., 2002. Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes. J. Cell. Sci.115:227.
19.
KaneiderN.C.EggerP.DunzendorferS.WiedermannC.J., 2001. Syndecan-4 as antithrombin receptor of human neutrophils. Biochem. Biophys. Res. Commun.287:42.
20.
DunzendorferS.KaneiderN.C.RabensteinerA.MeierhoferC.ReinischC.RomischJ.WiedermannC.J., 2001. Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood97:1079.
21.
Witko-SarsatV.RieuP.Descamps-LatschaB.LesavreP.Halbwachs-MecarelliL., 2000. Neutrophils: Molecules, functions and pathophysiological aspects. Lab. Invest.80:617.
22.
Lekstrom-HimesJ.A.GallinJ.I., 2000. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med.343:1703.
23.
KaneiderN.C.KaserA.TilgH.RicevutiG.WiedermannC.J., 2003. CD40 ligand-dependent maturation of human monocyte-derived dendritic cells by activated platelets. Int. J. Immunopathol. Pharmacol.16:225.
24.
CardenD.L.GrangerD.N., 2000. Pathophysiology of ischaemia-reperfusion injury. J. Pathol.190:255.
25.
GerardC.GerardN.P., 1994. The pro-inflammatory seven-trans-membrane segment receptors of the leukocyte. Curr. Opin. Immunol.6:140.
26.
RoemischJ.GrayE.HoffmannJ.N.WiedermannC.J., 2002. Antithrombin: A new look at the actions of a serine protease inhibitor. Blood Coagul. Fibrinolysis13:657.
27.
RanucciM.2002. Antithrombin III. Key factor in extracorporeal circulation. Minerva Anestesiol. 68:454.
